| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.29B | 22.04B | 21.24B | 22.17B | 19.63B | 18.73B |
| Gross Profit | 7.69B | 6.65B | 5.78B | 7.23B | 6.96B | 6.31B |
| EBITDA | 4.05B | 3.01B | 2.52B | 3.76B | 3.56B | 2.71B |
| Net Income | 2.02B | 1.31B | 966.36M | 2.41B | 1.72B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 36.71B | 35.89B | 32.45B | 33.05B | 28.99B | 26.50B |
| Cash, Cash Equivalents and Short-Term Investments | 7.39B | 5.11B | 4.02B | 6.99B | 5.41B | 5.79B |
| Total Debt | 7.81B | 8.02B | 5.60B | 5.46B | 2.91B | 2.65B |
| Total Liabilities | 12.99B | 12.53B | 10.01B | 10.46B | 8.52B | 7.52B |
| Stockholders Equity | 23.72B | 23.36B | 22.44B | 22.27B | 20.19B | 18.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -511.76M | -995.82M | -162.08M | -42.62M | 1.34B |
| Operating Cash Flow | 0.00 | 2.85B | 1.92B | 1.80B | 1.06B | 2.59B |
| Investing Cash Flow | 0.00 | -3.37B | -2.90B | -2.02B | -1.08B | -410.63M |
| Financing Cash Flow | 0.00 | 1.44B | -1.31B | 1.77B | -499.02M | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥17.94B | 9.90 | ― | 2.89% | 2.75% | -9.49% | |
80 Outperform | ¥30.59B | 15.21 | ― | 3.21% | 15.98% | 93.47% | |
73 Outperform | ¥34.50B | 4.97 | ― | 2.21% | 15.50% | 146.67% | |
71 Outperform | ¥25.50B | 13.70 | ― | 2.96% | 16.20% | -13.47% | |
68 Neutral | ¥34.64B | 8.42 | ― | 4.90% | -7.43% | -27.31% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥21.75B | ― | ― | 3.70% | 5.53% | 68.16% |